Meet Avance Clinical At BIO Asia-Taiwan 2025

Avance Clinical is excited to participate in the 11th BIO Asia-Taiwan International Convention, held from July 23 – 27, 2025, at the Taipei International Convention Center (TICC), as part of the Australian Pavilion.

As a premier event in Asia’s biotechnology calendar, BIO Asia-Taiwan fosters innovation, collaboration, and international partnerships. This year’s program features Business Partnering, Exhibitions, and Conferences, offering insights into emerging bio-health trends, technologies, and global expansion strategies.

Our team is looking forward to connecting with biotech leaders in Taiwan to discuss tailored solutions across the drug development lifecycle.

Strengthening Our Presence in Asia

Avance Clinical recently expanded its footprint in Asia with the opening of new operations in Taipei, Taiwan. This milestone enhances our ability to deliver seamless early-to-late phase clinical trials for global biotech clients, leveraging:

• Asia’s rapid regulatory pathways
• Diverse and accessible patient populations
• High-quality data accepted by the FDA and other major regulators

In March 2025, Avance Clinical also signed Memoranda of Understanding (MOUs) with four leading hospital clinical trial sites in Taiwan:

• Taichung Veterans General Hospital (TCVGH)
• Taipei Medical University (TMU)
• China Medical University Hospital (CMUH)
• Kaohsiung Medical University Chung-Ho Memorial Hospital (KMUH)

These strategic partnerships deepen our commitment to offering world-class clinical research solutions across the Asia-Pacific region, particularly for US biotech companies seeking reliable, accelerated pathways.